JMIA vs NEGG

Jumia Technologies exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating a near-total failure of fundamental health metrics. While the company maintains strong top-line revenue growth of 34.4%, this is offset by a devastating ROE of -109.87% and a Price-to-Book ratio of 32.26, which suggests extreme overvaluation relative to its equity. The lack of a Graham Number or Intrinsic Value reflects the absence of positive earnings, making the stock a highly speculative play. Despite bullish analyst targets, the deterministic data points to a high-risk profile with significant capital erosion over the long term.

NEGG exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 3/9, placing it in the 'Weak' health category. Despite a massive 1-year price surge of 1046.9%, this movement is decoupled from financial reality, as the company reports negative profit margins (-1.72%) and a deeply negative ROE (-19.72%). The extreme earnings miss (-272.5% surprise) and a low Quick Ratio (0.43) suggest significant liquidity risks and operational instability. The stock currently trades at a steep premium to book value (P/B 7.19) without the earnings growth to justify such a valuation.